
    
      Thirty-eight allo-HSCT recipients (Ëƒ100 days past post-transplant status) were included.
      Before and after 6-week IMT, maximal and submaximal exercise capacity, respiratory and
      peripheral muscle strength, pulmonary functions, dyspnea and fatigue perception, depression
      and quality of life were evaluated. Primary outcome measurement was respiratory muscle
      strength, secondary outcomes were exercise capacity, dyspnea, peripheral muscle strength,
      quality of life, fatigue and depression.
    
  